Member Info for Out4lunch

IUG continue to innovate and build interesting partnerships. Anything AI is in vogue and increasingly attracting a premium, IUG's offerings are solid and should shine through long after the hype has gone. ALL IMHO

I'm going to CoGX event at the O2 arena this week to research health and fintech start-ups, with a focus on AI.

GLALTH

Agreed, proper job good (as we say in the South west)

Also bonkers is the likely low SP reaction. However, I'm holding for gold and IMHO this is likely to be a good investment with good SP returns and the potential for dividends in the medium term, say 5-7 years.

When we get out of the market malaise (2-3 years?), I'm personally targeting an SP of 140 minimum.

I don't think this is ramping but it's just a view.

Glalth

And your evidence?

Excellent CEO, in control (as much as one can be) in a deal involving multiple parties and complex geo-political considerations. To win friends and influence people money and adept negotiation is always going to help.

We are being set up for success, on my part I'm keeping the eyes on the very considerable prize. Not concerned on short term price flip flopping or voices spreading FUD.

GLALTH

I've been hiding behind the sofa for several months as my explorer / pharma stocks have been the equivalent of a very scary Doctor Who episode.

However, on a few fronts, very much including ROCK, the worm (or drill) may have turned.

Here's hoping to getting into 'multiple pence' territory in 2023 then blowing the doors off in 2024.

GLALTH

And your reason for being here? I'm happy to respect your rights to make comments, why don't you respect others?

Leaving 12 month high. Where next?

Wouldn’t it be great if the webinar coincided with FDA full approval.
SP building nicely in the meantime.
With approval I’m expecting £2 before end of year.
Glalths

Stellar RNS trading update. Happy Tuesday fellow lths, any spreadsheet heroes going to venture impact on SP in near term and predictions for end of 2023?

Many thanks, top analysis SNN
KR O4L

Agreed, really solid, will be adding once initial spike over!
Any spreadsheet heroes have any considered view on SP forecasts for say 1 year and 5 years?
Glalth

Rns trading update shows revenue growth, good cash position and signals where transformational growth will come from (AI). Happy as a medium to long term hold.

Thanks for all the replies so far, seem very balanced and useful for newbies and us stalwarts alike.
As ever dyor

To help new investors, what do long term fumsters think will happen to the share price by the end of Q1, in 2 broad scenarios:
FDA approval (as the BOD expect) in Q1?
FDA approval is not given?

My prayers and thoughts for those innocents caught in conflict.
No one knows when the Ukraine catastrophe will stop, however, it will stop, mining activities will accelerate, the sale will conclude or not.
Whatever opinions (or agendas!) you may have, enjoy the new year festivities because 2024 could be our year my fellow EUA friends.
Glalth

This wonderful morning.
Oliver Twist is a great book, musical and film.

For some reason I can’t get that song out of my head.

GLAlth Christmas is coming

Not much new, however, a useful reminder of what has been achieved and confidence in the path FUM is on. James Barder is not exactly comfortable in positive messaging, at least we can join the dots. This is going to FLY IMHO DYOR.
My prediction (ok HOPE) is £1 will be breached Q1 and £3 by end 2023 as multiple bidders circle.
GLALTH

Profitable, resilient, sustainable dividend growth. That's why I'm invested and happy to hold.
Glalth

Or alternatively the II has done their homework, knows the market and is making a canny investment. We will see my friend, but generally I am encouraged.

Good performance; meeting expectations; substantial dividend; plenty of cash for investment and buybacks. What is not to like? May not re-rate on this years but underpins medium term SP growth, happy to hold.
Good luck LTHRS and welcome newbies